Hanefeld M, Pistrosch F, Bornstein SR, Birkenfeld AL. The metabolic vascular syndrome - guide to an individualized treatment. Rev Endocr Metab Disord 2016; 17: 5-17Hanefeld, Markolf,Pistrosch,etc.The metabolic vascular syndrome - guide to an individualized treatment[J].2016,17(1)....
2. Epidemiological involvement between metabolic syndrome (MetS) and cervical cancer 3. Metabolic factors 4. Regulation of metabolic remodeling 5. Nanocarriers for effective therapeutic delivery 6. Overview on systemic and localized drug delivery 7. Targeting cervical cancer through nanocarriers (NCs) 8....
After 1 year of treatment, there was a significant decrease in blood pressure with normalization of blood pressure in 70% of patients, decrease in the prevalence of metabolic syndrome by 50%, decrease of SOX, immune activity, and regression of hypertensive TOD. The main determinants of ...
Metabolic syndrome is a group of risk factors that include abdominal fat, high blood pressure, highblood sugar, and unhealthycholesterol levels. Treatment is focused on tackling each of these conditions. The goal is to cut your odds of blood vessel disease and heart disease, as well as diabetes...
Taken together, these findings suggest that a Mediterranean-style diet is a safe strategy for treatment of the metabolic syndrome and for helping to reduce the associated cardiovascular risk. Current guidelines on the management of the individual components of the metabolic syndrome emphasize that life...
This systematic review and meta-analysis examines the association of major food sources of fructose-containing sugars with incident metabolic syndrome.
De novo uridine-diphosphate-N-acetylglucosamine (UDP-GlcNAc) biosynthesis requires glucose, glutamine, acetyl-CoA and uridine, however GlcNAc salvaged from glycoconjugate turnover and dietary sources also makes a significant contribution to the intracell
Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. J. Nutr. Sci. Vitaminol (Tokyo) 54, 196–202 (2008). Article CAS Google Scholar Jürgens, G., Fell, A., Ledinski, G., Chen, Q. & Paltauf, ...
“metabotype” that constitute one or a set of compounds that reflect treatment effects [40], were elicited by tacrolimus. Distinct metabotypes after two days and seven days of treatment demonstrated significant and incremental effects imposed by continuous immunosuppressant treatment. Gut microbial ...
Lupus nephritis (LN) is a severe and common manifestation of systemic lupus erythematosus (SLE) that is frequently identified with a poor prognosis. Macrophages play an important role in its pathogenesis. Different macrophage subtypes have different effe